Last reviewed · How we verify

Bowel and colon cleansing preparation for colonoscopy — Treatment Landscape & Competitive Intelligence

Bowel and colon cleansing preparation for colonoscopy (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Bowel and colon cleansing preparation for colonoscopy, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Suprep Bowel Prep Kit POTASSIUM SULFATE Nihon Pharmaceutical Co., Ltd. 2010-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Nihon Pharmaceutical Co., Ltd. · 1 drug in Bowel and colon cleansing preparation for colonoscopy

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Bowel and colon cleansing preparation for colonoscopy:

Cite this brief

Drug Landscape (2026). Bowel and colon cleansing preparation for colonoscopy — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/bowel-and-colon-cleansing-preparation-for-colonoscopy. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing